Synovus Financial’s PAVmed PAVM Stock Holding History

Synovus Financial’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-89	Closed	-$79K	–	1968
2020 Q1	$79K	Buy	+89	New	+$72.8K	﹤0.01%	977

Other funds holding PAVM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

BAM

Belpointe Asset Management Reno, Nevada $2.74B AUM 20.71% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VWM

Vigilare Wealth Management Scottsdale, Arizona $326M AUM 21.58% 1-Year Est. Return

Synovus Financial's PAVM Position: Q2 2020 in Review

Synovus Financial sold out of PAVmed (PAVM) in Q2 2020, closing a stake of 89 shares — an estimated $79K sold.

Synovus Financial first reported a position in PAVM in Q1 2020 and held it in 1 quarter. The position peaked at $79K in Q1 2020. 52 funds tracked by Wall St. Rank hold PAVM as of Q2 2020.

Synovus Financial reported no remaining PAVmed position as of Q2 2020 after selling out during the quarter.
Synovus Financial sold 89 PAVmed shares in Q2 2020, an estimated $79K.
Synovus Financial first reported a position in PAVmed in Q1 2020 and held it in 1 quarter.
Synovus Financial's PAVmed position peaked at $79K in Q1 2020.
52 funds tracked by Wall St. Rank held PAVmed as of Q2 2020.

Based on Synovus Financial's 13F filing for Q2 2020, filed 10 Aug 2020.